A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.
about
Anti-Cancer Properties of the Naturally Occurring Aphrodisiacs: Icariin and Its DerivativesA novel anticancer agent SNG1153 inhibits growth of lung cancer stem/progenitor cellsIdentification of sphingosine kinase 1 (SphK1) as a primary target of icaritin in hepatocellular carcinoma cells.CC-223 blocks mTORC1/C2 activation and inhibits human hepatocellular carcinoma cells in vitro and in vivo.GRAM domain-containing protein 1A (GRAMD1A) promotes the expansion of hepatocellular carcinoma stem cell and hepatocellular carcinoma growth through STAT5Icaritin inhibits the expression of alpha-fetoprotein in hepatitis B virus-infected hepatoma cell lines through post-transcriptional regulation.High expression of miR-105-1 positively correlates with clinical prognosis of hepatocellular carcinoma by targeting oncogene NCOA1.AMPK-autophagy inhibition sensitizes icaritin-induced anti-colorectal cancer cell activity.Expression and clinical significance of C14orf166 in esophageal squamous cell carcinoma.Protein Regulator of Cytokinesis PRC1 Confers Chemoresistance and Predicts an Unfavorable Postoperative Survival of Hepatocellular Carcinoma Patients.Icaritin induces apoptotic and autophagic cell death in human glioblastoma cells.IL6-mediated inflammatory loop reprograms normal to epithelial-mesenchymal transition+ metastatic cancer stem cells in preneoplastic liver of transforming growth factor beta-deficient β2-spectrin+/- mice.The changing landscape of clinical trial and approval processes in China.Targeting BCR-ABL+ stem/progenitor cells and BCR-ABL-T315I mutant cells by effective inhibition of the BCR-ABL-Tyr177-GRB2 complex.Preclinical study of CC223 as a potential anti-ovarian cancer agent.TGF-β1 signaling pathway serves a role in HepG2 cell regulation by affecting the protein expression of PCNA, gankyrin, p115, XIAP and survivinAnalytic and Dynamic Secretory Profile of Patient-Derived Cytokine-Induced Killer Cells.Hepatic inflammation-fibrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine.Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight.Ganoderic acid A exerts antitumor activity against MDA-MB-231 human breast cancer cells by inhibiting the Janus kinase 2/signal transducer and activator of transcription 3 signaling pathwayOverexpressed C14orf166 associates with disease progression and poor prognosis in non-small-cell lung cancer
P2860
Q26738330-87573711-134E-4077-90FA-7C61FAF1563DQ28817916-0E122909-6FDF-409A-A205-20332FDBAFEAQ33618473-FD07EAAB-1701-4BBF-B795-DE20283AE4C0Q36320156-C5201670-7A11-46F1-980C-752466844A85Q37227925-C1B0A0B5-3D4F-4E51-A49D-E620BD13A68EQ37696374-AA841963-FF67-4027-96FF-549015028F0CQ37707012-20985643-FBC7-4D6B-8B82-C498BC918FE5Q37716430-A8DFEEB7-C825-416B-9B27-44E24C72813AQ37720044-575D62F8-24EB-40F7-978D-206308D296AFQ37738084-66465A98-53C7-492F-8BD5-F02E1D031CC2Q38728168-E309BF9A-AFBE-41E5-A7CE-15CBB901F175Q38730296-1CBCC22B-19F1-46A6-9A35-5C94380698F9Q39134733-FAF2D6B4-4AE2-489B-AF2D-AF231DDA18F3Q41279430-43D1E06A-2D81-4D3D-9EED-96612EAABA1DQ41709197-0635E476-62D0-4FF3-8616-0521962F9EB6Q41893637-28A6BA5F-BD5C-4FB4-A71A-8076D1F388FEQ42274903-2113BB81-A5E4-45CF-A269-8E0828B94452Q50872061-AC281622-49F0-4730-8D46-878C98B32678Q52345488-F5224E1E-8A01-4F16-A52F-BD2348D36CE7Q58572515-7A8CEADE-CAEC-412B-8A96-8AB1D6E46EFDQ58741896-30A836DE-F5B4-447D-877C-79CC15A6310E
P2860
A novel anti-cancer agent Icaritin suppresses hepatocellular carcinoma initiation and malignant growth through the IL-6/Jak2/Stat3 pathway.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
A novel anti-cancer agent Icar ...... h the IL-6/Jak2/Stat3 pathway.
@ast
A novel anti-cancer agent Icar ...... h the IL-6/Jak2/Stat3 pathway.
@en
type
label
A novel anti-cancer agent Icar ...... h the IL-6/Jak2/Stat3 pathway.
@ast
A novel anti-cancer agent Icar ...... h the IL-6/Jak2/Stat3 pathway.
@en
prefLabel
A novel anti-cancer agent Icar ...... h the IL-6/Jak2/Stat3 pathway.
@ast
A novel anti-cancer agent Icar ...... h the IL-6/Jak2/Stat3 pathway.
@en
P2093
P2860
P356
P1433
P1476
A novel anti-cancer agent Icar ...... h the IL-6/Jak2/Stat3 pathway.
@en
P2093
Hongying Jia
Jianguo Zhou
Jianjun Zhao
Jianming Ying
Jianqiang Cai
Lingzhi Sun
P2860
P304
31927-31943
P356
10.18632/ONCOTARGET.5578
P407
P577
2015-09-10T00:00:00Z